Demographics Demographics Demographics Value
M/F M/F 8/61
Mean age (range) Mean age (range) 52 (18-86)
Relevant clinical history Relevant clinical history Relevant clinical history Relevant clinical history
Asthma Asthma 7/69
Chronic urticaria Chronic urticaria 3/69
Aeroallergy Aeroallergy 4/69
Hypothyroidism Hypothyroidism 4/69
Celiac disease Celiac disease 1/69
Chronic pain Chronic pain 1/69
Diabetes mellitus type II Diabetes mellitus type II 1/69
Breast carcinoma Breast carcinoma 1/69
Reason for referral Reason for referral Reason for referral Reason for referral
Anxiety Anxiety 23/69
Multiple anaphylaxis Multiple anaphylaxis 1/69
Refused by vaccination center Refused by vaccination center 4/69
Suspected hypersensitivity to unrelated drugs 1/4
Suspected hypersensitivity to macrogol 1/4
Anaphylaxis to diclofenac (which contains tromethamine) in clinical history 1/4
Possibly angio-edema after unknown vaccine, more than 10 years ago 1/4
Symptoms after 1st or 2nd dose (†) Symptoms after 1st or 2nd dose (†) 41/69
(Pre)syncope, hypotension, palpitations immediate after vaccination 14/41
Dyspnea immediate after vaccination 8/41
Dysphagia immediate after vaccination 2/41
Hoarseness immediate after vaccination 1/41
Nausea immediate after vaccination 2/41
Headache immediate after vaccination 2/41
Pruritus immediate after vaccination 7/41
Flushing immediate after vaccination 1/41
Urticaria immediate after vaccination 4/41
Urticaria > 1 day after vaccination 2/41
Unspecified skin rash 4/41
Angio-edema / sensation of swelling immediate after vaccination 12/41
Angio-edema / sensation of swelling >1 day after vaccination 2/41
Measurement of acute serum tryptase 0/41